Puma BiotechnologyvsThermo Fisher Scientific

PBYI and TMO stock compared: price, dividend, valuation and results, from SEC filings.

PBYI

Puma Biotechnology Inc

$7.12

Value $362M

-1.39%
PBYI's page

TMO

Thermo Fisher Scientific Inc

$688.94

Value $256B

-0.58%
TMO's page

Puma Biotechnology (PBYI) has a market value of $362M and Thermo Fisher Scientific (TMO) $256B. Over the last year, with dividends, PBYI moved +40.7% and TMO +20.0%. The P/E is 15.2 for PBYI and 36.2 for TMO. Dividend yield: PBYI none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    PBYI$362M

    TMO$256B

    TMO is 707 times PBYI

  • Revenue, 12 months

    PBYI$232M

    TMO$47.4B

    TMO is 204 times PBYI

  • Net income, 12 months

    PBYI$24M

    TMO$7.1B

    TMO is 297 times PBYI

  • Operating margin

    PBYI11.3%

    TMO17.9%

    6.6 points apart

  • ROIC

    PBYI12.8%

    TMO8.2%

    4.6 points apart

  • P/E

    PBYI15.2

    TMO36.2

    TMO is 2.4 times PBYI

  • Dividend yield

    PBYI0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    PBYI+111.3%

    TMO+9.6%

    101.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

PBYI+111.4%

TMO+9.6%

10020030020222023202420252026
Returns by period
PeriodPBYIWith dividendsTMOWith dividends
1 year since November 18, 2025+40.7%Price +40.7%+20.0%Price +19.6%
3 years since November 17, 2023+84.9%+22.7% a yearPrice +84.9%+49.1%+14.3% a yearPrice +47.7%
5 years since November 18, 2021+111.3%+16.1% a yearPrice +111.3%+9.6%+1.9% a yearPrice +8.0%
10 years since November 21, 2016-83.7%-16.6% a yearPrice -83.7%+384.8%+17.1% a yearPrice +371.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

PBYIPuma BiotechnologyTMOThermo Fisher Scientific

Valuation

PBYITMO
Valuation
Price$7.12$688.94
Market value$362M$256B
Enterprise value (EV)$307M$291B
P/E15.236.2
P/E, 5-year median9.632.7
P/B2.54.7
EV/EBIT11.734.4
Free cash flow yield12.7%3.0%

Results and growth

PBYITMO
Results and growth
Revenue, 12 months$232M$47.4B
Net income, 12 months$24M$7.1B
Free cash flow, 12 months$46M$7.6B
Earnings per share, 12 months$0.46$18.96
Revenue growth, year on year-0.9%3.9%
Revenue growth a year, past+0.3%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

PBYITMO
Margins and returns on capital
Gross margin73.6%–
Operating margin11.3%17.9%
Net margin10.3%14.9%
ROIC12.8%8.2%
ROE18.1%13.4%

Balance sheet

PBYITMO
Balance sheet
Cash$101M$6.1B
Total debt$50M$41.4B
Net debt / EBITDA-1.53.7
Interest cover12.9×5.5×

Dividends and buybacks

PBYITMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: PBYI or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Puma Biotechnology or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($256B) is about 706.5 times Puma Biotechnology ($362M), at today's prices.

How did PBYI and TMO stock do over the last 10 years?

Since November 21, 2016, PBYI's price moved -83.7% and TMO's +371.3%. With dividends: PBYI -83.7% (-16.6% a year), TMO +384.8% (+17.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, PBYI or TMO?

The dividend yield at today's price is none for Puma Biotechnology and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of PBYI and TMO?

At today's price, the P/E is 15.2 for PBYI and 36.2 for TMO. The median of the last five years was 9.6 and 32.7, which shows where each stands against its own past.

Which has the higher profit margins, Puma Biotechnology or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 10.3% for Puma Biotechnology and 14.9% for Thermo Fisher Scientific, and the operating margin 11.3% and 17.9%. Revenue was $232M and $47.4B.

Which is the better investment, Puma Biotechnology or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.